Report

Global Sickle Cell Treatment Market is segmented by Treatment Modality (Bone Marrow Transplant, Blood Transfusion, and Pharmacotherapy), End User (Hospitals, Specialty Clinics, and Others),Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Sickle Cell treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Sickle Cell treatment Market, by Treatment Modality, 2019-2027 (USD Billion)
1.2.3. Sickle Cell treatment Market, by End user, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Sickle Cell treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Sickle Cell treatment Market Dynamics
3.1. Sickle Cell treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing research and development activity
3.1.1.2. Increasing prevalence of sickle cell disease
3.1.2. Market Restraint
3.1.2.1. High cost of treatments
3.1.3. Market Opportunities
3.1.3.1. Widespread population of African descent
Chapter 4. Global Sickle Cell treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Sickle Cell treatment Market, by Treatment Modality
5.1. Market Snapshot
5.2. Global Sickle Cell treatment Market by Treatment Modality, Performance - Potential Analysis
5.3. Global Sickle Cell treatment Market Estimates & Forecasts by Treatment modality 2018-2027 (USD Billion)
5.4. Sickle Cell treatment Market , Sub Segment Analysis
5.4.1. Blood Transfusion
5.4.2. Bone Marrow Transplant
5.4.3. Pharmacotherapy
Chapter 6. Global Sickle Cell treatment Market, by End user
6.1. Market Snapshot
6.2. Global Sickle Cell treatment Market by End User, Performance - Potential Analysis
6.3. Global Sickle Cell treatment Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
6.4. Sickle Cell treatment Market , Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Specialty Clinics
6.4.3. Others
Chapter 7. Global Sickle Cell treatment Market, Regional Analysis
7.1. Sickle Cell treatment Market , Regional Market Snapshot
7.2. North America Sickle Cell treatment Market
7.2.1. U.S. Sickle Cell treatment Market
7.2.1.1. Treatment modality breakdown estimates & forecasts, 2018-2027
7.2.1.2. End user breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Sickle Cell treatment Market
7.3. Europe Sickle Cell treatment Market Snapshot
7.3.1. U.K. Sickle Cell treatment Market
7.3.2. Germany Sickle Cell treatment Market
7.3.3. France Sickle Cell treatment Market
7.3.4. Spain Sickle Cell treatment Market
7.3.5. Italy Sickle Cell treatment Market
7.3.6. Rest of Europe Sickle Cell treatment Market
7.4. Asia-Pacific Sickle Cell treatment Market Snapshot
7.4.1. China Sickle Cell treatment Market
7.4.2. India Sickle Cell treatment Market
7.4.3. Japan Sickle Cell treatment Market
7.4.4. Australia Sickle Cell treatment Market
7.4.5. South Korea Sickle Cell treatment Market
7.4.6. Rest of Asia Pacific Sickle Cell treatment Market
7.5. Latin America Sickle Cell treatment Market Snapshot
7.5.1. Brazil Sickle Cell treatment Market
7.5.2. Mexico Sickle Cell treatment Market
7.6. Rest of The World Sickle Cell treatment Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Bristol Myers Squibb Co.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Global Blood Therapeutics Inc.
8.2.3. Bluebird Biotechnology
8.2.4. F.Hoffmann-La Roche
8.2.5. Emmaus Medical Inc.
8.2.6. Eli-Lilly and Co.
8.2.7. Baxter Inc.
8.2.8. Medunik USA.Inc.
8.2.9. Addmedica Inc.
8.2.10. Glycomimetics Inc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption